Video

Dr. Pearlstone on Biomarker Testing in the Community

Author(s):

David Pearlstone, MD

David Pearlstone, MD, Co-Division Chief, Breast Oncology from John Theurer Cancer Center on Biomarker Testing in the Community Setting

David Pearlstone, MD, Co-Division Chief, Breast Oncology from John Theurer Cancer Center, on Biomarker Testing in the Community Setting.

Related Videos
David Sallman, MD
Oleg Gluz, MD
Benjamin Adam Weinberg, MD, associate professor, medicine, Georgetown Lombardi Comprehensive Cancer Center
Yungan Tao, MD
Jared Weiss, MD
Guru P. Sonpavde, MD
Martin H. Voss, MD
Sally Lau, MD
Hope S. Rugo, MD
Amrita Krishnan, MD, executive medical director, Hematology, director, Judy and Bernard Briskin Multiple Myeloma Center, professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope
Related Content
Aditya Bardia, MD, MPH, FASCO, of UCLA
October 15th 2024

TROP2 Offers Attractive Therapeutic Target in Breast Cancer and Other Solid Tumors

OncLive On Air
September 11th 2024

Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress

Josh Riggs, of Oncocyte
October 13th 2024

Assay Predicts Response to Neoadjuvant Atezolizumab Plus Chemotherapy in TNBC

MedNews Week
September 4th 2024

Park and Graff Explore the Evolving Role of CDK4/6 Inhibitors in Metastatic Breast Cancer

FDA
October 11th 2024

FDA Approves Single-Dose, Intravenous Paclitaxel Biosimilar for Breast Cancer

FDA
October 10th 2024

FDA Approves Inavolisib Plus Palbociclib/Fulvestrant for Endocrine-Resistant, PIK3CA-Mutated, HR+, HER2– Advanced Breast Cancer